Alimera Sciences
ALIM
ALIM was delisted on the 13th of September, 2024.
52 hedge funds and large institutions have $258M invested in Alimera Sciences in 2024 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 11 increasing their positions, 7 reducing their positions, and 14 closing their positions.
93% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 14
57% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 7
38% more capital invested
Capital invested by funds: $187M → $258M (+$71M)
33% more funds holding
Funds holding: 39 → 52 (+13)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
95% less call options, than puts
Call options by funds: $5K | Put options by funds: $105K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$3.49M |
| 2 |
BlackRock
New York
|
+$3.2M |
| 3 |
GCL
Glazer Capital LLC
New York
|
+$1.96M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$924K |
| 5 |
State Street
Boston,
Massachusetts
|
+$858K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Clearline Capital
New York
|
-$8.13M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$5.93M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$1.92M |
| 4 |
ACM
Altium Capital Management
New York
|
-$1.42M |
| 5 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$915K |
ALIM Hedge Fund Activity: Q2 2024 in Review
52 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Alimera Sciences (ALIM) for Q2 2024, worth a combined $258M — up 38% from $187M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ALIM positions and 14 closed out — a net gain of 13 holders — while 11 added to existing stakes and 7 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $3.49M. The largest seller was Clearline Capital, exiting entirely with an estimated $8.13M sold.
- 52 institutional investors held Alimera Sciences (ALIM) as of Q2 2024, up from 39 in Q1 2024.
- Funds reported $258M of Alimera Sciences stock for Q2 2024, up 38% quarter-over-quarter.
- 27 funds opened new Alimera Sciences positions in Q2 2024 and 14 closed out, a net change of +13 holders.
- The largest Alimera Sciences buyer in Q2 2024 was JP Morgan Chase, an estimated $3.49M added.
- The largest Alimera Sciences seller in Q2 2024 was Clearline Capital, an estimated $8.13M sold.
Based on aggregated 13F filings for Q2 2024.